# Limonin

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/limonin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** Limonin A, Citrus limonoid, Obacunone derivative, 7α-Acetoxy-1,7-dihydroxy-3,7-dimethyl-8-oxo-1,8a-dihydronaphthalene-2-carboxylate, Citrus bitter compound

## Overview

Limonin is a tetracyclic triterpenoid limonoid found primarily in citrus fruits, concentrated in seeds and juice. It exerts anti-inflammatory and [antioxidant](/ingredients/condition/antioxidant) effects largely by suppressing NF-κB signaling and inhibiting [pro-inflammatory cytokine](/ingredients/condition/inflammation) production including TNF-α and IL-6.

## Health Benefits

• Anti-inflammatory effects, demonstrated in animal studies reducing [pro-inflammatory cytokine](/ingredients/condition/inflammation)s in models of lung injury and colitis. [4] • Potential in reducing psoriasis-like skin inflammation by inhibiting immune cell expansion and cytokine mRNA expression in mice. [3] • Suppression of NF-κB and TLR4/NF-κB pathways, contributing to its anti-inflammatory actions in preclinical studies. [4] • Inhibition of mTORC1 and reduction of [mitochondrial](/ingredients/condition/energy) ROS in psoriasis models. [3] • Downregulation of iNOS gene expression, which may support [liver health](/ingredients/condition/detox). [4]

## Mechanism of Action

Limonin suppresses the NF-κB signaling pathway by inhibiting IκB kinase (IKK) phosphorylation, thereby preventing nuclear translocation of NF-κB and reducing transcription of pro-inflammatory genes encoding TNF-α, IL-1β, and IL-6. It also downregulates MAPK pathway activation, specifically p38 and ERK1/2 phosphorylation, further attenuating inflammatory cascades. Additionally, limonin modulates Nrf2 [antioxidant](/ingredients/condition/antioxidant) response elements and inhibits COX-2 enzyme expression, contributing to its dual [anti-inflammatory](/ingredients/condition/inflammation) and cytoprotective profile.

## Clinical Summary

Most evidence for limonin comes from in vitro cell studies and rodent models rather than human clinical trials, limiting definitive conclusions about efficacy. Animal studies using lipopolysaccharide (LPS)-induced lung injury and colitis models have shown measurable reductions in TNF-α, IL-6, and IL-1β levels at doses ranging from 10–50 mg/kg body weight. A murine psoriasis model demonstrated that limonin inhibited CD4+ [T-cell](/ingredients/condition/immune-support) expansion and reduced [cytokine](/ingredients/condition/inflammation) mRNA expression including IL-17A and IFN-γ. No large-scale randomized controlled trials in humans have been published to date, so all therapeutic claims remain preliminary and extrapolated from preclinical data.

## Nutritional Profile

Limonin is a triterpenoid limonoid compound found primarily in citrus fruits (oranges, lemons, grapefruit, limes), concentrated in seeds and pith. It is not a macronutrient or micronutrient but a bioactive phytochemical. Typical concentrations in citrus juice range from 0.5–10 mg/L, with freshly squeezed juice containing higher levels that increase over time due to enzymatic conversion from limonin glucoside (the non-bitter precursor). Citrus seeds can contain up to 40–50 mg/g dry weight. As a pure compound it contributes negligible calories, protein, fat, or fiber. Bioavailability is moderate; limonin undergoes hepatic [metabolism](/ingredients/condition/weight-management) and is detectable in plasma after oral consumption, though exact human pharmacokinetic data is limited. It is lipophilic, suggesting enhanced absorption when consumed with dietary fats. Its primary relevance is as a bioactive — not a nutrient — with documented [antioxidant](/ingredients/condition/antioxidant), [anti-inflammatory](/ingredients/condition/inflammation), and potential anticancer properties at concentrations achievable through dietary citrus intake or supplementation.

## Dosage & Preparation

Clinically studied dosages for limonin are unavailable due to the lack of human trials; animal studies report ranges of 5-50 mg/kg. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Limonin is generally regarded as safe at dietary levels found in citrus consumption, but high-dose supplemental forms lack robust human safety data. Because limonin is metabolized via cytochrome P450 enzymes, particularly CYP3A4, it may interact with drugs sharing this metabolic pathway including statins, immunosuppressants like cyclosporine, and certain anticoagulants. Pregnant or breastfeeding individuals should avoid supplemental doses beyond food-derived amounts due to insufficient safety evidence. Individuals with citrus allergies or those on [immunomodulatory](/ingredients/condition/immune-support) therapy should consult a physician before using concentrated limonin supplements.

## Scientific Research

No human clinical trials directly on limonin exist, but preclinical studies in animals show promising [anti-inflammatory](/ingredients/condition/inflammation) effects. A related trial (PMID: 9654110) examined D-limonene in cancer patients, but not limonin itself. [2]

## Historical & Cultural Context

Limonin itself lacks documented historical or traditional medicinal uses. It is a modernly studied phytochemical derived from citrus fruits, which have general traditional uses for [digestion](/ingredients/condition/gut-health) and [inflammation](/ingredients/condition/inflammation).

## Synergistic Combinations

Limonin pairs well with Nobiletin (citrus flavonoid), as both suppress NF-κB signaling via complementary upstream targets — limonin acting on TLR4/NF-κB and nobiletin inhibiting IκB phosphorylation — producing additive anti-inflammatory effects relevant to skin and gut inflammation. Quercetin is a strong companion due to its shared inhibition of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s (TNF-α, IL-6, IL-1β) and its ability to enhance bioavailability of lipophilic compounds like limonin through modulation of intestinal efflux transporters (P-glycoprotein). Hesperidin (citrus flavanone) complements limonin's TLR4 pathway suppression with its own COX-2 inhibitory activity, creating a multi-target anti-inflammatory stack naturally co-occurring in citrus. Piperine from black pepper can further enhance limonin's bioavailability by inhibiting CYP3A4 and P-glycoprotein, potentially increasing plasma concentrations by 20–40% based on analogous studies with other triterpenoids.

## Frequently Asked Questions

### What foods are highest in limonin?

Limonin is found almost exclusively in citrus fruits, with the highest concentrations in citrus seeds and the white pith. Navel orange juice can contain measurable limonin levels (up to 300–400 ppb), which is also responsible for the delayed bitterness sometimes experienced in processed orange juice. Lemon and grapefruit seeds are among the richest known dietary sources.

### Does limonin have anticancer properties?

Preclinical studies indicate limonin can induce apoptosis in cancer cell lines including breast, colon, and neuroblastoma cells, partly through activation of caspase-3 and suppression of Bcl-2 anti-apoptotic proteins. It has also shown inhibition of tumor cell migration in vitro by downregulating matrix metalloproteinases (MMP-2 and MMP-9). However, no human clinical trials have confirmed anticancer efficacy, and these findings should not be interpreted as evidence that limonin treats or prevents cancer.

### How does limonin reduce inflammation?

Limonin primarily reduces inflammation by blocking the NF-κB pathway — specifically by preventing phosphorylation and degradation of IκBα, which normally sequesters NF-κB in the cytoplasm. This keeps NF-κB inactive and reduces transcription of cytokines like TNF-α, IL-1β, and IL-6. Simultaneously, limonin suppresses MAPK signaling (p38 and ERK1/2), providing a secondary anti-inflammatory mechanism independent of NF-κB.

### What is the typical dosage of limonin used in research?

Animal studies have most commonly used doses between 10 and 50 mg/kg body weight administered orally or intraperitoneally to observe anti-inflammatory and antioxidant effects. Extrapolating these doses to humans using standard allometric scaling suggests an approximate human equivalent dose of roughly 1–8 mg/kg, though no established human therapeutic dose exists. Supplemental products vary widely in concentration, and no consensus dosing guidelines have been established by regulatory or clinical bodies.

### Can limonin interact with medications?

Limonin is processed through cytochrome P450 enzymes, particularly CYP3A4, meaning it has the potential to compete with or alter the metabolism of drugs dependent on this enzyme system. Medications at risk for interaction include statins (atorvastatin, simvastatin), calcineurin inhibitors like cyclosporine, and certain benzodiazepines or calcium channel blockers. Individuals taking these medications should speak with a healthcare provider before supplementing with concentrated limonin extracts.

### How does limonin's bioavailability compare to other citrus flavonoids?

Limonin has relatively poor oral bioavailability due to its large molecular structure and limited absorption in the small intestine, though gut microbiota can metabolize it into more absorbable compounds. Limonin undergoes hepatic metabolism and conjugation, resulting in low systemic concentrations even at dietary doses. Co-consumption with dietary fats may enhance absorption compared to limonin alone, though this has not been extensively studied in humans.

### Is limonin safe for pregnant or breastfeeding women?

There is insufficient human clinical data on limonin safety during pregnancy and lactation, and supplemental limonin should be avoided by pregnant or breastfeeding women as a precaution. Animal studies have not identified teratogenic effects, but no controlled trials in pregnant populations exist. Consuming limonin from whole citrus fruits in normal dietary amounts is generally considered safe during pregnancy.

### What is the current strength of clinical evidence for limonin in humans versus animal studies?

Most evidence for limonin's anti-inflammatory and health benefits comes from preclinical animal studies and in vitro research, with very limited human clinical trials published to date. Animal models of colitis, psoriasis-like inflammation, and lung injury have shown promising results, but these findings have not been consistently replicated in human populations. More rigorous, placebo-controlled human trials are needed to establish efficacy and optimal dosing for therapeutic applications.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*